Menu

Alpha Stories

Iowa Alpha-1 education day August 28 features talks on importance of exercise, getting to positive, advocacy opportunities and More

Tuesday, July 6, 2010
DES MOINES, IA – Josh Stolpe, a Cardiopulmonary Specialist at Mercy Medical Center, will explain “The Importance of Exercise” at the Alpha-1 Education Day on August 28. Jeff Wilson, MD, Professor of Medicine at the University of Iowa will lead off with “The Basics of Alpha-1 Lung Disease,” followed by “The Basics of Alpha-1 Liver Disease,” by Dawn...
Divider

FDA approves Kamada's IV drug Glassia as 4th US augmentation therapy for Alpha-1

Friday, July 2, 2010
Israeli biopharmaceutical company Kamada Inc. has been granted approval by the US Food and Drug Administration for Glassia, its intravenous augmentation therapy to treat emphysema due to Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin Deficiency, or Alpha-1, is the most important known genetic risk factor for emphysema. Glassia is the fourth IV augmentation drug marketed in the United...
Divider

Kathy Haduck receives Helen Chase Walsh Memorial Award

Kathy Haduck receives Helen Chase Walsh Memorial Award
Thursday, June 17, 2010
AlphaNet Coordinator Kathy Haduck of Blandburg, PA, was honored with the Helen Chase Walsh Memorial Award at the recent annual education conference of the Alpha-1 Association in Orlando, FL. The award is presented each year by the Walsh family to someone who demonstrates a love of life, courage and spirit in living with Alpha-1, and compassion for and service to others Haduck, who could not...
Divider

Do you have the scoop on Alpha-1?

Thursday, June 17, 2010
Darin and Megan Chittick know exactly why it’s important to support Alpha-1 fundraisers. Their daughter, McKinley Chittick, who is now three years old, was diagnosed with Alpha-1 when she was just a month old. She developed severe jaundice at birth that lasted longer than usual. Because of the jaundice, she was given a blood test to see if she had Alpha-1. And she did. Now, McKinley...
Divider

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"

$1 million donation by Cadwgans to help Alpha-1 Foundation "find new therapies and ultimately, a cure"
Wednesday, June 16, 2010
Ruth and Gordon E. Cadwgan, Jr., made a surprise announcement at this past weekend’s national education conference in Orlando: the donation of a million dollars to the Alpha-1 Foundation from themselves and Gordon Cadwgan, Sr. Gordon Cadwgan, Jr. explained the timing of the family’s donation for Alpha-1 research. It came up in a recent conversation between father and son: “My...
Divider

Foundation scientific director receives "outstanding investigator" award from Hungarian Respiratory Society

Wednesday, June 16, 2010
SOPRON, HUNGARY—Alpha-1 Foundation Scientific Director Adam Wanner, MD, recently received the “Outstanding Investigator Award” from the Hungarian Respiratory Society at its biennial meeting. Wanner gave the keynote speech at the conference of some 1,500 physicians. His subject was “Alpha-1 Antitrypsin Deficiency for Clinicians.” The Hungarian Respiratory Society...
Divider

Foundation presents Building Friends for a Cure awards

Monday, June 14, 2010
ORLANDO, FL—The Alpha-1 Foundation presented its Building Friends for a Cure awards Friday evening during the Alpha-1 Association’s annual educational conference. The Alpha-1 Foundation presented awards to the following. All-Star Award—Team Alpha-1 3rd annual George Washington Bridge Walk, New York/New Jersey, Joe Reidy and Lori Tartell Alpha-1 5K Walk, Miami, FL, Florida...
Divider

Alpha-1 protein to be tested as treatment for Type 1 diabetes

Wednesday, June 9, 2010
MarketWire DENVER, CO—Omni Bio Pharmaceutical, Inc. announced that the Barbara Davis Center for Childhood Diabetes has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to initiate a Phase I and II clinical trial evaluating alpha-1 antitrypsin protein to treat Type I diabetics. Type 1 diabetes, formerly called juvenile diabetes, is usually diagnosed in...
Divider
First9101112131415161718